Dep. Dermatology and Allergology, Ruhr-University Bochum
Bochum, 44791, Germany
NCT Number: NCT00350116
Objective: To test the efficacy and tolerability of a vitamin B12 cream for the treatment of chronic plaque psoriasis.
Design: Multicenter, double-blind, randomized, placebo-controlled trial.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Bochum, 44791, Germany
Objective: To test the efficacy and tolerability of a vitamin B12 cream for the treatment of chronic plaque psoriasis.
Design: Multicenter, double-blind, randomized, placebo-controlled trial. Setting: ambulatory patients in research or referral centers. Patients: Volunteer sample of 51 patients with chronic plaque psoriasis. Interventions: All Patients applied vitamin B12 cream twice daily for 8 weeks to one side of the body and placebo to the other.
Main outcome measures: Modified Psoriasis Area and Severity Index (PASI) at weeks 0, 2, 4, 6 and 8. Thickness and density of 3 references plaques determined by 20 MHz sonography. Assessment of efficiency and tolerability by patients and investigators.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ruhr University of Bochum
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06011733
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis
Beijing, China
View Trial DetailsNCT01872546
Chronic Plaque Psoriasis
Poitiers, France
View Trial DetailsNCT03536884
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis
Santa Ana, California, United States
View Trial DetailsNCT03410992
Arthritis, Arthritis, Psoriatic
San Diego, California, United States
View Trial Details